Loading fund overlap…
5 of 91 unique stocks in common · Jaccard: 5.5%
A weighted portfolio overlap of 5.74% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.74 is allocated to the exact same companies at the same relative proportions. The schemes share 5 common holdings.
The largest overlapping asset in their portfolios is Cipla, which commands a weight of 2.89% in HDFC Flexi Cap Fund and 6.08% in Nippon India Pharma Fund. Holding both schemes increases your concentration in Cipla rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in Nippon |
|---|---|---|
| CiplaPharmaceuticals & Biotechnology | 2.89% | 6.08% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 1.18% | 5.05% |
| LupinPharmaceuticals & Biotechnology | 0.74% | 8.55% |
| Apollo Hospitals EnterpriseHealthcare Services | 0.58% | 5.41% |
| Metropolis HealthcareHealthcare Services | 0.35% | 0.53% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.